Influenza A virus H5N1 vaccine (Solvay)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza A virus H5N1 vaccine (Solvay)
Drug Alias NamePandemic H5N1 egg-based vaccine - Solvay
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza in Birds
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFinland
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSolvay Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSolvay SaSolvay Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsInfluenza in Birds

Other Information

ATC CodeN/A
Related LinksN/A